Erionite is a naturally occurring fibrous zeolite mineral that is highly carcinogenic. It is commonly found in volcanic and hydrothermal environments. Erionite has been linked to mesothelioma, a type of cancer that affects the lining of the lungs and abdomen. Its fibrous structure, similar to asbestos, is believed to be responsible for its carcinogenic properties. The fibrous nature of erionite allows it to easily penetrate the respiratory system, where it can cause inflammation and cell damage. Erionite is studied extensively due to its association with mesothelioma, particularly in areas where erionite-containing dust is prevalent. The research aims to understand the mechanisms by which erionite causes cancer, develop methods for detecting erionite exposure, and find ways to mitigate the health risks associated with this mineral.'
erionite: erionite was SY to zeolite (NM); use zeolites (NM) to search through 1993; RN given is for cpd with unknown MF [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 61565 |
MeSH ID | M0221374 |
Synonym |
---|
erionite |
12510-42-8 |
erionite ((k0-1na0-1ca0-0.5)10(al10si26o72).30h2o) |
hsdb 7765 |
Q26841277 |
Erionite is classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen. It is considered today similar to or even more carcinogenic than the six regulated asbestos minerals. Erionites are found in many parts of the world, including the western United States.
Erionite has a higher potency in the lung than asbestos. familial clustering of malignant mesothelioma suggests a genetic predisposition to this cancer among affected individuals.
Erionite has similar chemical and physical properties to amphibole asbestos, which induces autoantibodies in mice. Erionite deposits have been reported in many countries; however, it is only in the area of three villages of Cappadocia, Turkey, that environmental exposure to erionite was demonstrated to be the cause of an epidemic of mesothelioma.
Excerpt | Reference | Relevance |
---|---|---|
"Erionite has a higher degree of carcinogenicity with possible genetic transmission of erionite susceptibility in an autosomal dominant fashion." | ( Clinical and prognostic features of erionite-induced malignant mesothelioma. Demirer, E; Elamin, EM; Ghattas, CF; Radwan, MO, 2015) | 1.41 |
"Erionite has a higher potency in the lung than asbestos and familial clustering of malignant mesothelioma suggests a genetic predisposition to this cancer among affected individuals." | ( Malignant pleural mesothelioma in Turkey, 2000-2002. Demir, AU; Emri, S, 2004) | 1.04 |
"Erionite has similar chemical and physical properties to amphibole asbestos, which induces autoantibodies in mice. " | ( Erionite induces production of autoantibodies and IL-17 in C57BL/6 mice. Davis, C; Ng, KW; Peña, C; Pfau, JC; Zebedeo, CN, 2014) | 3.29 |
"Erionite has been the culprit of numerous malignant mesothelioma cases in Europe and even in North America." | ( Clinical and prognostic features of erionite-induced malignant mesothelioma. Demirer, E; Elamin, EM; Ghattas, CF; Radwan, MO, 2015) | 1.41 |
"Erionite has emerged as the most important example of nonasbestos-mediated cause of mesothelioma in regions such as Turkey where exposure to this type of fiber is highly prevalent. " | ( Mesothelioma not associated with asbestos exposure. Gibbs, A; Jasani, B, 2012) | 1.82 |
"Erionite has a higher potency in the lung than asbestos and familial clustering of malignant mesothelioma suggests a genetic predisposition to this cancer among affected individuals." | ( Malignant pleural mesothelioma in Turkey, 2000-2002. Demir, AU; Emri, S, 2004) | 1.04 |
"Erionite deposits have been reported in many countries; however, it is only in the area of three villages of Cappadocia, Turkey, that environmental exposure to erionite has been demonstrated to be the cause of an epidemic of the disease mesothelioma." | ( Erionite series minerals: mineralogical and carcinogenic properties. Dogan, AU; Dogan, M; Hoskins, JA, 2008) | 2.51 |
Excerpt | Reference | Relevance |
---|---|---|
" The toxic action of fibrous erionite on M0-THP-1 cells is manifested since the early steps (2 h) of the experiment while the cytotoxicity of crocidolite and chrysotile gradually increases during the time span of the experiment." | ( Acute cytotoxicity of mineral fibres observed by time-lapse video microscopy. Alessandrini, A; Almonti, V; Avallone, R; Bassi, AM; Di Giuseppe, D; Filaferro, M; Gualtieri, AF; Mescola, A; Mirata, S; Ragazzini, G; Scarfì, S; Scognamiglio, V; Vitale, G, 2022) | 1.01 |
Excessive fibre burden and fibre aggregation during injection that especially for chrysotile would likely not represent what humans would be exposed to. Conversely, erionite was mutagenic in a dose-response manner at concentrations greater than 6 microg/cm(2)
Excerpt | Relevance | Reference |
---|---|---|
" However, since epidemiological studies are difficult to perform in Turkey, the incidence and the dose-response curve have not been thoroughly examined." | ( Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort. Hillerdal, G; Metintas, M; Metintas, S, 1999) | 0.55 |
" Conversely, erionite was mutagenic in a dose-response manner at concentrations greater than 6 microg/cm(2) and the mutagenic potential of erionite was significantly enhanced by the addition of ferrous ions." | ( The effect of iron on the biological activities of erionite and mordenite. Dutta, PK; Fach, E; Kristovich, R; Long, JF; Waldman, WJ; Williams, MV, 2003) | 0.94 |
" Due to unequal dosing based on number of fibres per mass for chrysotile with respect to crocidolite and erionite, excessive fibre burden and fibre aggregation during injection that especially for chrysotile would likely not represent what humans would be exposed to, caution must be taken in extrapolating our results based on instillation in experimental animals to human inhalation." | ( Assessment of asbestos body formation by high resolution FEG-SEM after exposure of Sprague-Dawley rats to chrysotile, crocidolite, or erionite. Belpoggi, F; Gandolfi, NB; Gualtieri, AF; Pollastri, S; Tibaldi, E, 2016) | 0.85 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (17.07) | 18.2507 |
2000's | 30 (36.59) | 29.6817 |
2010's | 34 (41.46) | 24.3611 |
2020's | 4 (4.88) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (51.62) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 12 (13.95%) | 6.00% |
Case Studies | 1 (1.16%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 73 (84.88%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |